TGFB1 and idiopathic pulmonary fibrosis: Therefore, the contribution of platelet-derived TGFβ1 in mediating human IPF disease remains unknown, although global depletion of either platelets or TGFβ1 is not feasible therapeutic options for patients with IPF.